BCL2L1 and melanoma: Furthermore, observations of increased Mcl-1 and Bcl-xL levels in thin primary melanomas as well as in metastatic malignant melanomas but not in benign nevi, suggest that up regulation of these proteins represents an early event associated with malignant transformation [10]–[12].